In today's trading, Xortx Therapeutics Inc shares opened at $4.90 and closed at $4.57. It traded at a low of $4.46 to a high of $4.90.

The price dipped -8.60 percent from the previous day's close of $5.00.

During the day across North America, the TSX Composite closed 0.08% at 22185.25, the S&P 500 closed -0.20% at 5243.77, the Dow Jones Industrial Average closed -0.60% at 39566.85 and the Nasdaq Composite closed 0.11% at 16396.83.

Xortx Therapeutics Inc traded under XRTX on the Toronto Venture Exchange (TSX-V).

Trading volume was 9,779 on 43 total trades. On average, Xortx Therapeutics Inc has traded 8,672 shares over 5 days and 16,126 year-to-date.

The TSX-V overall saw 1,257 price advancers against 4,032 declines and 79 unchanged.

During the prior 52 weeks, XRTX.VN has traded as high as $10.62 (April 20,2023) and low as $2.65 (December 28,2023). Moreover, in the last 12 months, Xortx Therapeutics Inc's shares have dipped -20.66 percent, while they have soared 57.59% year-to-date.

Following today's trading, Xortx Therapeutics Inc has a market capitalization of $14.49 million on a float of 2,899 shares outstanding. Its annual EPS is $-3.60.

Xortx Therapeutics Inc is a TSX Biotechnology company headquartered in Calgary, CAN.

Xortx Therapeutics Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..